RxDoctor Payments Data

Eric Emerson, MD

Plastic and Reconstructive Surgery · Gastonia, NCNPI 1134111289

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,059 of the $2,309 with a category attached, or 89.2%. 15 manufacturers reported payments, led by Mentor Worldwide LLC at 41.2% of the total. Reporting peaked in 2023 at $887 and has fallen 70.9% since, to $258 in 2025. That places this record below the midpoint for plastic and reconstructive surgery clinicians in NC, where the typical reported total is $2,773.

$2,309in general payments, 2019–2025

Across 69 payments — averaging $33.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Mentor Worldwide LLC$952
  • AbbVie$564
  • Sientra, Inc.$382
  • Access Pro Medical, LLC$90
  • TELA Bio, Inc.$73
  • Sun Pharmaceutical Industries Inc.$54
  • plus $194 from 9 others
$5,085in research payments, 2019–2025

Across 5 payments — averaging $1017.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Mentor Worldwide LLC$3K
  • Sientra, Inc.$2K

What the payments were for

  • Speaking & faculty fees$25011%
  • Food & beverage$2,05989%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Mentor Worldwide LLC20$952
AbbVie(2 entities)27$564
Sientra, Inc.3$382
Access Pro Medical, LLC1$90
TELA Bio, Inc.2$73
Sun Pharmaceutical Industries Inc.4$54
UCB, Inc.3$48
Integra Lifesciences Corporation2$31
LEO Pharma Inc.1$25
Optumhealth Care Solutions, LLC1$19
Pacira Pharmaceuticals Incorporated1$16
Pierre Fabre Pharmaceuticals, Inc.1$16
Medtronic1$14
Galderma Laboratories, L.p.1$12
DUSA Pharmaceuticals, Inc.1$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,309 in reported general payments places this provider in the 45th percentile of 55 plastic and reconstructive surgery providers in North Carolina.

See all plastic and reconstructive surgery providers in North Carolina

Medicare billing

Part B allowed, 2024
$350,796
Medicare patients
588
Services billed
2,887

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Fluorouracil78$6,117
Doxycycline Hyclate92$642
SsdSilver Sulfadiazine18$499
Ketoconazole15$291
Silver Sulfadiazine15$234
Ondansetron OdtOndansetron12$21

Paid to pharmacies, not to this prescriber.

Other plastic and reconstructive surgery in Gastonia

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →